Novel targets and regulatory ordeal by QT interval.
Ritter
J M
JM
D000818:Animals; D004562:Electrocardiography / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D051381:Rats; D013927:Thrombosis / Q000188:drug therapy
D010972:Platelet Activating Factor
Br J Clin Pharmacol. 2008 Sep;66(3):396-404
18662287
Br J Clin Pharmacol. 2010 Apr;69(4):401-10
20406224
Br J Pharmacol. 2010 Jan;159(1):34-48
19775279
Br J Clin Pharmacol. 2008 Feb;65(2):154-7
18251756
Arch Mal Coeur Vaiss. 1966 Feb;59(2):263-72
4956181
Br J Clin Pharmacol. 2009 Sep;68(3):318-9
19740388
Br J Clin Pharmacol. 2010 May;69(5):425-6
20573077
J Pharmacol Exp Ther. 1997 Jan;280(1):114-21
8996188
Br J Pharmacol. 2010 Jan;159(1):5-11
20141515
Br J Clin Pharmacol. 2008 Sep;66(3):341-4
18782140
Br J Pharmacol. 2010 Jan;159(1):70-6
20141519
Drugs. 2007;67(3):457-74
17335300
Br J Clin Pharmacol. 2010 Apr;69(4):391-400
20406223
Nat Rev Immunol. 2009 Jan;9(1):62-70
19104500
Br J Clin Pharmacol. 2008 Sep;66(3):375-85
18662288
Biochem Pharmacol. 2005 May 1;69(9):1325-31
15826603
Br J Pharmacol. 2010 Jan;159(1):58-69
19563537